Latest News Feed

NEW SURVEY: Four in Five Americans Support Reforms to the Patent System to Lower Drug Prices
Press Release Oct 20, 2025
NEW SURVEY: Four in Five Americans Support Reforms to the Patent System to Lower Drug Prices

A new report from the Franklin & Marshall's Center for Opinion Research and the Initiative for Medicines, Access & Knowledge (I-MAK) reveal Americans' top concerns on drug pricing.
I-MAK Report Reveals How Extending Patent Terms Inflates Prices of Medicare's Top Negotiated Drugs
Press Release Jun 16, 2025
I-MAK Report Reveals How Extending Patent Terms Inflates Prices of Medicare's Top Negotiated Drugs

Data brief analyzes patenting and pricing practices for blockbuster drugs Eliquis and semaglutide medications (Ozempic, Rybelsus, Wegovy), continuing the acclaimed Overpatented, Overpriced series that exposes flaws in the U.S. patent system
New I-MAK Report Exposes Patent Abuse and Market Monopolization Behind GLP-1 Drug Prices
Press Release Apr 10, 2025
New I-MAK Report Exposes Patent Abuse and Market Monopolization Behind GLP-1 Drug Prices

The Heavy Price of GLP-1 Drugs reveals how pharmaceutical companies are exploiting the patent system, delaying competition, and driving up costs for patients